tiprankstipranks
Trending News
More News >
Aurobindo Pharma Ltd (IN:AUROPHARMA)
:AUROPHARMA
India Market

Aurobindo Pharma Ltd (AUROPHARMA) Income Statement

Compare
3 Followers

Aurobindo Pharma Ltd Income Statement

Last quarter (Q1 2026), Aurobindo Pharma Ltd's total revenue was ₹78.68B, an increase of 3.98% from the same quarter last year. In Q1, Aurobindo Pharma Ltd's net income was ₹8.25B. See Aurobindo Pharma Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 317.24B₹ 290.02B₹ 248.55B₹ 234.55B₹ 247.75B
Gross Profit
₹ 182.40B₹ 160.16B₹ 132.14B₹ 130.06B₹ 145.85B
Operating Expenses
₹ 62.39B₹ 55.66B₹ 51.09B₹ 52.00B₹ 51.82B
Depreciation and Amortization
₹ 14.49B₹ 13.73B₹ 11.23B₹ 10.05B₹ 9.41B
EBITDA
₹ 64.36B₹ 57.64B₹ 36.34B₹ 43.11B₹ 53.95B
Operating Income
₹ 120.01B₹ 104.50B₹ 81.05B₹ 78.06B₹ 94.03B
Other Income/Expenses
₹ -69.35B₹ -60.70B₹ -54.92B₹ -44.33B₹ -20.60B
Pretax Income
₹ 50.66B₹ 43.80B₹ 26.13B₹ 33.73B₹ 73.44B
Net Income
₹ 34.86B₹ 31.73B₹ 19.27B₹ 26.48B₹ 53.35B
Per Share Metrics
Basic EPS
₹ 59.81₹ 54.15₹ 32.90₹ 45.20₹ 91.05
Diluted EPS
₹ 59.81₹ 54.15₹ 32.90₹ 45.19₹ 91.05
Weighted Average Shares Outstanding
582.87M 585.94M 585.94M 586.00M 585.94M
Weighted Average Shares Outstanding (Diluted)
582.87M 585.94M 585.94M 585.94M 585.94M
Currency in INR

Aurobindo Pharma Ltd Earnings and Revenue History